Oruka Therapeutics (ORKA) Profit After Tax (2010 - 2024)

Oruka Therapeutics' Profit After Tax history runs 15 years deep, the most recent figure standing at -$2.7 million for Q2 2024.

• In Q2 2024, Profit After Tax fell 80.95% year-over-year to -$2.7 million; the TTM figure through Jun 2024 stood at -$7.2 million (down 13.69% YoY), while the FY2023 annual figure was -$5.3 million, up 46.21% from the prior year.
• Profit After Tax for Q2 2024 stood at -$2.7 million, down from -$2.0 million in the prior quarter.
• The five-year high for Profit After Tax was -$1.1 million in Q4 2023, with the low at -$5.7 million in Q4 2021.
• The 5-year median for Profit After Tax is -$2.2 million (2022), against an average of -$2.7 million.
• The sharpest annual moves came in 2020 and 2022: Profit After Tax slumped 318.03% in 2020, then soared 79.32% in 2022.
• Oruka Therapeutics' Profit After Tax stood at -$5.1 million in 2020, then declined by 10.75% to -$5.7 million in 2021, then jumped by 79.32% to -$1.2 million in 2022, then grew by 7.24% to -$1.1 million in 2023, then slumped by 145.91% to -$2.7 million in 2024.
• Business Quant data shows ORKA's Profit After Tax at -$2.7 million in Q2 2024, -$2.0 million in Q1 2024, and -$1.1 million in Q4 2023.